Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters











Database
Language
Publication year range
1.
Genet Mol Res ; 15(2)2016 Jun 03.
Article in English | MEDLINE | ID: mdl-27323123

ABSTRACT

Radiotherapy is one of the most important treatments for esophageal cancer, but radioresistance remains a major challenge. Previous studies have shown that microRNAs (miRNAs or miRs) are involved in human cancers. miR-124 has been widely reported in various cancers and it is intimately involved in proliferation, cell cycle regulation, apoptosis, migration, and invasion of cancer cells. The aim of this study was to explore the relationship between the miR-124/cyclin-dependent kinase 4 (CDK4) axis and the radiosensitivity of esophageal cancer cells. In this study, we identified the reduced expression of miR-124 in 18 paired esophageal cancer tissues compared to their matched normal tissues. In order to investigate the physiological role of miR-124 in esophageal cancer, the cell counting kit-8 (CCK-8) assay and wound healing assay were performed, and the results suggest that miR-124 overexpression decreases tumor growth and aggression. Next, we detected the effects of ectopic miR-124 expression on the apoptosis of an esophageal cancer cell line (TE-1) following radiotherapy. Using the CCK-8 assay and Hoechst 332528 stain, we found that ectopic expression of miR-124 led to a higher percentage of apoptotic cells. Finally, we identified that CDK4 is a direct target of miR-124 in TE-1 cells using target prediction algorithms and a luciferase reporter assay. Moreover, western blot assay confirmed that CDK4 was downregulated during miR-124 transfection. Taken together, we illustrate that the miR-124/CDK4 axis plays an important role in radiation sensitivity of human esophageal cancer cells by targeting CDK4.


Subject(s)
Cyclin-Dependent Kinase 4/biosynthesis , Esophageal Neoplasms/genetics , MicroRNAs/genetics , Radiation Tolerance/genetics , Apoptosis/genetics , Cell Cycle Checkpoints/genetics , Cell Line, Tumor , Cell Proliferation , Cyclin-Dependent Kinase 4/genetics , Esophageal Neoplasms/pathology , Esophageal Neoplasms/radiotherapy , Gene Expression Regulation, Neoplastic , Humans , MicroRNAs/biosynthesis
2.
Genet Mol Res ; 14(2): 6018-27, 2015 Jun 01.
Article in English | MEDLINE | ID: mdl-26125801

ABSTRACT

We investigated the therapeutic effect of Xin Mai Jia (XMJ) on atherosclerosis (AS) in rats. Rat models of AS were established by peritoneally injecting vitamin D, feeding a high-fat diet, and inducing balloon injuries in rats. The stomachs of the rats were irrigated continuously for 10 weeks with XMJ. Blood lipid- and hemorheology-related indices of blood samples were detected. Pathological changes in the right common carotid arterial tissues were also determined. The protein expression levels of endothelial nitric oxide synthase, angio-tensin-1, and endothelin-1 were determined by western blotting. XMJ reduced cholesterol, trigylecride, and low-density lipoprotein levels as well as blood viscosity, sedimentation, and hematocrit. Furthermore, XMJ alleviated vascular endothelial injury and reduced/eliminated atherosclerotic plaques. In contrast, XMJ significantly increased the endothelium-dependent relaxing response of the AS rat models. The western blotting results showed that XMJ upregulated endothelial nitric oxide synthase but downregulated angiotensin-1 and endothelin-1. XMJ prevented the development of AS by regulating blood lipid levels, hemorheology, and vascular function.


Subject(s)
Atherosclerosis/blood , Atherosclerosis/drug therapy , Cholesterol/blood , Medicine, Chinese Traditional , Angiotensins/biosynthesis , Angiotensins/blood , Animals , Atherosclerosis/chemically induced , Diet, High-Fat , Endothelin-1/biosynthesis , Endothelin-1/blood , Endothelium, Vascular/metabolism , Endothelium, Vascular/pathology , Gene Expression , Humans , Lipoproteins, LDL/blood , Male , Nitric Oxide/metabolism , Nitric Oxide Synthase Type III/biosynthesis , Nitric Oxide Synthase Type III/blood , Rats , Vitamin D/toxicity
SELECTION OF CITATIONS
SEARCH DETAIL